Avrobio Inc (AVRO)
1.38
-0.01
(-0.72%)
USD |
NASDAQ |
May 21, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Avrobio Enterprise Value: -28.08M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | -28.08M |
| May 17, 2024 | -28.08M |
| May 16, 2024 | -28.08M |
| May 15, 2024 | -28.98M |
| May 14, 2024 | -32.57M |
| May 13, 2024 | -29.87M |
| May 10, 2024 | -35.26M |
| May 09, 2024 | -34.36M |
| May 08, 2024 | -33.91M |
| May 07, 2024 | -34.36M |
| May 06, 2024 | -34.81M |
| May 03, 2024 | -35.71M |
| May 02, 2024 | -35.26M |
| May 01, 2024 | -35.72M |
| April 30, 2024 | -37.06M |
| April 29, 2024 | -37.06M |
| April 26, 2024 | -36.17M |
| April 25, 2024 | -37.30M |
| April 24, 2024 | -37.07M |
| April 23, 2024 | -36.17M |
| April 22, 2024 | -36.62M |
| April 19, 2024 | -36.62M |
| April 18, 2024 | -34.83M |
| April 17, 2024 | -35.72M |
| April 16, 2024 | -33.93M |
| Date | Value |
|---|---|
| April 15, 2024 | -33.93M |
| April 12, 2024 | -33.48M |
| April 11, 2024 | -33.48M |
| April 10, 2024 | -34.38M |
| April 09, 2024 | -33.93M |
| April 08, 2024 | -33.93M |
| April 05, 2024 | -33.48M |
| April 04, 2024 | -31.69M |
| April 03, 2024 | -32.13M |
| April 02, 2024 | -33.03M |
| April 01, 2024 | -33.03M |
| March 28, 2024 | -40.58M |
| March 27, 2024 | -41.47M |
| March 26, 2024 | -41.47M |
| March 25, 2024 | -43.27M |
| March 22, 2024 | -40.58M |
| March 21, 2024 | -41.92M |
| March 20, 2024 | -40.58M |
| March 19, 2024 | -41.47M |
| March 18, 2024 | -40.13M |
| March 15, 2024 | -39.68M |
| March 14, 2024 | -41.05M |
| March 13, 2024 | -40.15M |
| March 12, 2024 | -40.60M |
| March 11, 2024 | -39.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-118.31M
Minimum
Mar 07 2022
673.96M
Maximum
Feb 11 2020
123.25M
Average
12.57M
Median
Enterprise Value Benchmarks
| Axonics Inc | 3.113B |
| Catalent Inc | 14.77B |
| AIM ImmunoTech Inc | 13.60M |
| Protalix BioTherapeutics Inc | 59.91M |
| Armata Pharmaceuticals Inc | 183.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.808M |
| Total Expenses (Quarterly) | 7.941M |
| EPS Diluted (Quarterly) | -0.15 |
| Earnings Yield | 50.00% |